Economic Burden of Neurologic Toxicities Associated with Treating Relapsed Refractory Diffuse Large B-Cell Lymphoma in the United States
AMERICAN HEALTH AND DRUG BENEFITS（2020）
Key words
CAR T-cell therapy,cytotoxic therapy,healthcare costs,neurologic adverse events,relapsed or refractory diffuse large B-cell lymphoma,targeted therapy
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined